Free Trial

Seres Therapeutics (MCRB) SEC Filings & 10K Form

Seres Therapeutics logo
$18.88 -0.47 (-2.43%)
Closing price 08/27/2025 04:00 PM Eastern
Extended Trading
$19.03 +0.15 (+0.82%)
As of 04:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Seres Therapeutics SEC Filings

DateFilerForm TypeView
08/06/2025
11:23 AM
FMR LLC (Filed by)
Seres Therapeutics (Subject)
Form SCHEDULE 13G/A
08/06/2025
9:00 AM
Seres Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2025
6:05 AM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2025
4:58 PM
Ausiello Dennis A (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2025
4:34 PM
Fraser Claire (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2025
4:38 PM
Berenson Stephen (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025
9:03 AM
FMR LLC (Filed by)
Seres Therapeutics (Subject)
Form SCHEDULE 13G/A
05/07/2025
9:00 AM
Seres Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2025
6:05 AM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/14/2025
3:13 PM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2025
3:05 PM
Dere Willard H (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2025
3:05 PM
Ausiello Dennis A (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2025
3:05 PM
Kender Richard N (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2025
3:05 PM
Berenson Stephen (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2025
3:05 PM
Graves Kurt (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2025
3:05 PM
Fraser Claire (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2025
3:05 PM
Biondi Paul (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2025
10:43 AM
Seres Therapeutics (Filer)
Form DEF 14A
03/13/2025
10:37 AM
Seres Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/13/2025
10:24 AM
Seres Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/13/2025
6:07 AM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2025
7:05 PM
Seres Therapeutics (Issuer)
von Moltke Lisa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
7:07 PM
DesRosier Thomas (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
7:08 PM
Seres Therapeutics (Issuer)
Shaff Eric D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
7:10 PM
Henn Matthew R. (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
7:11 PM
Seres Therapeutics (Issuer)
Young Teresa L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
7:00 AM
Seres Therapeutics (Issuer)
Woerle Hans-Juergen (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/06/2025
7:00 AM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/06/2025
7:05 AM
Seres Therapeutics (Issuer)
Woerle Hans-Juergen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
7:06 AM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
6:00 AM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/19/2024
3:20 PM
Seres Therapeutics (Issuer)
von Moltke Lisa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
3:21 PM
DesRosier Thomas (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
9:30 AM
Seres Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2024
7:05 AM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2024
5:33 PM
Seres Therapeutics (Issuer)
von Moltke Lisa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/29/2024
5:23 PM
Seres Therapeutics (Issuer)
Young Teresa L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/29/2024
5:24 PM
Seres Therapeutics (Issuer)
Shaff Eric D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/29/2024
5:26 PM
DesRosier Thomas (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/29/2024
5:27 PM
Henn Matthew R. (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/14/2024
11:15 PM
Seres Therapeutics (Filer)
Form EFFECT
Musk’s Project Colossus could mint millionaires (Ad)

I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.tc pixel

All the details are waiting for you now — but you need to act before the September 1st funding windo
10/11/2024
3:34 PM
Seres Therapeutics (Filer)
Form 424B3
10/02/2024
7:15 AM
NESTLE SA (Reporting)
Seres Therapeutics (Issuer)
Societe des Produits Nestle S.A. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/02/2024
7:15 AM
NESTLE SA (Filed by)
Seres Therapeutics (Subject)
Form SC 13D/A
10/01/2024
3:46 PM
Seres Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
09/26/2024
3:13 PM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2024
7:30 AM
Seres Therapeutics (Filer)
Form DEFA14A
09/12/2024
6:05 AM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:MCRB) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners